The mission of Discovering Dengue Drugs – Together is to discover promising drug leads that stop the replication of viruses within the Flaviviridae family. Diseases caused by Flaviviridae include:

  • Dengue
  • Hepatitis C
  • West Nile
  • Yellow fever

The project has been extended to include leishmaniasis.

The approach used by the project is to develop drugs that inhibit the viral NS3 protease. The NS3 protease is an enzyme critical for virus replication, and its amino acid sequence and atomic structure are very similar among the different disease–causing flaviviruses. The researchers are using AutoDock to find compounds that bind strongly with NS3.


Main article: Publications

Tomlinson, S. M.; Malmstrom, R. D.; Watowich, S. J. (2009),
"New Approaches to Structure-Based Discovery of Dengue Protease Inhibitors",
Infect Disord Drug Targets 9 (3): 327 - 343, doi:

External links

Discovering Dengue Drugs - Together

Dddt info image


Dddt badge

Phase 1 complete
August 21, 2007
Completion date
August 26, 2009
Research software
Software version

Project news

Loading RSS data...

Known issues

Loading RSS data...

Screensaver screenshot